tirzepatide and ulcerative colitis Based on current data, GLP-1s appear generally well tolerated in people with IBD, but we do not yet have large, long-term trials in people with UC, so I tell patients we should GLP-1 Benefits For People With

For adults with T2D at high risk of major CV events Ozempic (semaglutide) pill: proven CV risk reduction 6 (semaglutide) pill: proven CV risk reduction 6 Start Ozempic pill today in adults with T2D who are at high risk for major CV events Ozempic pill can significantly lower the risk of MACE 6,7 pill can significantly lower the risk of MACE 6,7 Primary composite endpoint: Reduction in risk of MACE with semaglutide tablets 14 mg vs placebo when both were added to SOC in adults with T2D and established CVD and/or CKD 6 Time to first confirmed MACE (CV death, nonfatal MI, or nonfatal stroke) 6,7,b NNT 50 Number needed to treat to prevent d 1 MACE (3 years) 7,d Ozempic tablets 1.5 mg, 4 mg, and 9 mg are an updated formulation with increased bioavailability

Take 80-125mg after meals or when burping becomes bothersome

Gastaldelli A, Cusi K, Fernndez Land L, et al

Its only in the past few years that this class of drugs has really become famous